Cargando…

An in vitro testing strategy towards mimicking the inhalation of high aspect ratio nanoparticles

BACKGROUND: The challenge remains to reliably mimic human exposure to high aspect ratio nanoparticles (HARN) via inhalation. Sophisticated, multi-cellular in vitro models are a particular advantageous solution to this issue, especially when considering the need to provide realistic and efficient alt...

Descripción completa

Detalles Bibliográficos
Autores principales: Endes, Carola, Schmid, Otmar, Kinnear, Calum, Mueller, Silvana, Camarero-Espinosa, Sandra, Vanhecke, Dimitri, Foster, E Johan, Petri-Fink, Alke, Rothen-Rutishauser, Barbara, Weder, Christoph, Clift, Martin JD
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4189630/
https://www.ncbi.nlm.nih.gov/pubmed/25245637
http://dx.doi.org/10.1186/s12989-014-0040-x
_version_ 1782338394416742400
author Endes, Carola
Schmid, Otmar
Kinnear, Calum
Mueller, Silvana
Camarero-Espinosa, Sandra
Vanhecke, Dimitri
Foster, E Johan
Petri-Fink, Alke
Rothen-Rutishauser, Barbara
Weder, Christoph
Clift, Martin JD
author_facet Endes, Carola
Schmid, Otmar
Kinnear, Calum
Mueller, Silvana
Camarero-Espinosa, Sandra
Vanhecke, Dimitri
Foster, E Johan
Petri-Fink, Alke
Rothen-Rutishauser, Barbara
Weder, Christoph
Clift, Martin JD
author_sort Endes, Carola
collection PubMed
description BACKGROUND: The challenge remains to reliably mimic human exposure to high aspect ratio nanoparticles (HARN) via inhalation. Sophisticated, multi-cellular in vitro models are a particular advantageous solution to this issue, especially when considering the need to provide realistic and efficient alternatives to invasive animal experimentation for HARN hazard assessment. By incorporating a systematic test-bed of material characterisation techniques, a specific air-liquid cell exposure system with real-time monitoring of the cell-delivered HARN dose in addition to key biochemical endpoints, here we demonstrate a successful approach towards investigation of the hazard of HARN aerosols in vitro. METHODS: Cellulose nanocrystals (CNCs) derived from cotton and tunicates, with differing aspect ratios (~9 and ~80), were employed as model HARN samples. Specifically, well-dispersed and characterised CNC suspensions were aerosolised using an “Air Liquid Interface Cell Exposure System” (ALICE) at realistic, cell-delivered concentrations ranging from 0.14 to 1.57 μg/cm(2). The biological impact (cytotoxicity, oxidative stress levels and pro-inflammatory effects) of each HARN sample was then assessed using a 3D multi-cellular in vitro model of the human epithelial airway barrier at the air liquid interface (ALI) 24 hours post-exposure. Additionally, the testing strategy was validated using both crystalline quartz (DQ12) as a positive particulate control in the ALICE system and long fibre amosite asbestos (LFA) to confirm the susceptibility of the in vitro model to a fibrous insult. RESULTS: A rapid (≤4 min), controlled nebulisation of CNC suspensions enabled a dose-controlled and spatially homogeneous CNC deposition onto cells cultured under ALI conditions. Real-time monitoring of the cell-delivered CNC dose with a quartz crystal microbalance was accomplished. Independent of CNC aspect ratio, no significant cytotoxicity (p > 0.05), induction of oxidative stress, or (pro)-inflammatory responses were observed up to the highest concentration of 1.57 μg/cm(2). Both DQ12 and LFA elicited a significant (p < 0.05) pro-inflammatory response at sub-lethal concentrations in vitro. CONCLUSION: In summary, whilst the present study highlights the benign nature of CNCs, it is the advanced technological and mechanistic approach presented that allows for a state of the art testing strategy to realistically and efficiently determine the in vitro hazard concerning inhalation exposure of HARN. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12989-014-0040-x) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4189630
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-41896302014-10-23 An in vitro testing strategy towards mimicking the inhalation of high aspect ratio nanoparticles Endes, Carola Schmid, Otmar Kinnear, Calum Mueller, Silvana Camarero-Espinosa, Sandra Vanhecke, Dimitri Foster, E Johan Petri-Fink, Alke Rothen-Rutishauser, Barbara Weder, Christoph Clift, Martin JD Part Fibre Toxicol Research BACKGROUND: The challenge remains to reliably mimic human exposure to high aspect ratio nanoparticles (HARN) via inhalation. Sophisticated, multi-cellular in vitro models are a particular advantageous solution to this issue, especially when considering the need to provide realistic and efficient alternatives to invasive animal experimentation for HARN hazard assessment. By incorporating a systematic test-bed of material characterisation techniques, a specific air-liquid cell exposure system with real-time monitoring of the cell-delivered HARN dose in addition to key biochemical endpoints, here we demonstrate a successful approach towards investigation of the hazard of HARN aerosols in vitro. METHODS: Cellulose nanocrystals (CNCs) derived from cotton and tunicates, with differing aspect ratios (~9 and ~80), were employed as model HARN samples. Specifically, well-dispersed and characterised CNC suspensions were aerosolised using an “Air Liquid Interface Cell Exposure System” (ALICE) at realistic, cell-delivered concentrations ranging from 0.14 to 1.57 μg/cm(2). The biological impact (cytotoxicity, oxidative stress levels and pro-inflammatory effects) of each HARN sample was then assessed using a 3D multi-cellular in vitro model of the human epithelial airway barrier at the air liquid interface (ALI) 24 hours post-exposure. Additionally, the testing strategy was validated using both crystalline quartz (DQ12) as a positive particulate control in the ALICE system and long fibre amosite asbestos (LFA) to confirm the susceptibility of the in vitro model to a fibrous insult. RESULTS: A rapid (≤4 min), controlled nebulisation of CNC suspensions enabled a dose-controlled and spatially homogeneous CNC deposition onto cells cultured under ALI conditions. Real-time monitoring of the cell-delivered CNC dose with a quartz crystal microbalance was accomplished. Independent of CNC aspect ratio, no significant cytotoxicity (p > 0.05), induction of oxidative stress, or (pro)-inflammatory responses were observed up to the highest concentration of 1.57 μg/cm(2). Both DQ12 and LFA elicited a significant (p < 0.05) pro-inflammatory response at sub-lethal concentrations in vitro. CONCLUSION: In summary, whilst the present study highlights the benign nature of CNCs, it is the advanced technological and mechanistic approach presented that allows for a state of the art testing strategy to realistically and efficiently determine the in vitro hazard concerning inhalation exposure of HARN. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12989-014-0040-x) contains supplementary material, which is available to authorized users. BioMed Central 2014-09-23 /pmc/articles/PMC4189630/ /pubmed/25245637 http://dx.doi.org/10.1186/s12989-014-0040-x Text en © Endes et al.; licensee BioMed Central Ltd. 2014 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Endes, Carola
Schmid, Otmar
Kinnear, Calum
Mueller, Silvana
Camarero-Espinosa, Sandra
Vanhecke, Dimitri
Foster, E Johan
Petri-Fink, Alke
Rothen-Rutishauser, Barbara
Weder, Christoph
Clift, Martin JD
An in vitro testing strategy towards mimicking the inhalation of high aspect ratio nanoparticles
title An in vitro testing strategy towards mimicking the inhalation of high aspect ratio nanoparticles
title_full An in vitro testing strategy towards mimicking the inhalation of high aspect ratio nanoparticles
title_fullStr An in vitro testing strategy towards mimicking the inhalation of high aspect ratio nanoparticles
title_full_unstemmed An in vitro testing strategy towards mimicking the inhalation of high aspect ratio nanoparticles
title_short An in vitro testing strategy towards mimicking the inhalation of high aspect ratio nanoparticles
title_sort in vitro testing strategy towards mimicking the inhalation of high aspect ratio nanoparticles
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4189630/
https://www.ncbi.nlm.nih.gov/pubmed/25245637
http://dx.doi.org/10.1186/s12989-014-0040-x
work_keys_str_mv AT endescarola aninvitrotestingstrategytowardsmimickingtheinhalationofhighaspectrationanoparticles
AT schmidotmar aninvitrotestingstrategytowardsmimickingtheinhalationofhighaspectrationanoparticles
AT kinnearcalum aninvitrotestingstrategytowardsmimickingtheinhalationofhighaspectrationanoparticles
AT muellersilvana aninvitrotestingstrategytowardsmimickingtheinhalationofhighaspectrationanoparticles
AT camareroespinosasandra aninvitrotestingstrategytowardsmimickingtheinhalationofhighaspectrationanoparticles
AT vanheckedimitri aninvitrotestingstrategytowardsmimickingtheinhalationofhighaspectrationanoparticles
AT fosterejohan aninvitrotestingstrategytowardsmimickingtheinhalationofhighaspectrationanoparticles
AT petrifinkalke aninvitrotestingstrategytowardsmimickingtheinhalationofhighaspectrationanoparticles
AT rothenrutishauserbarbara aninvitrotestingstrategytowardsmimickingtheinhalationofhighaspectrationanoparticles
AT wederchristoph aninvitrotestingstrategytowardsmimickingtheinhalationofhighaspectrationanoparticles
AT cliftmartinjd aninvitrotestingstrategytowardsmimickingtheinhalationofhighaspectrationanoparticles
AT endescarola invitrotestingstrategytowardsmimickingtheinhalationofhighaspectrationanoparticles
AT schmidotmar invitrotestingstrategytowardsmimickingtheinhalationofhighaspectrationanoparticles
AT kinnearcalum invitrotestingstrategytowardsmimickingtheinhalationofhighaspectrationanoparticles
AT muellersilvana invitrotestingstrategytowardsmimickingtheinhalationofhighaspectrationanoparticles
AT camareroespinosasandra invitrotestingstrategytowardsmimickingtheinhalationofhighaspectrationanoparticles
AT vanheckedimitri invitrotestingstrategytowardsmimickingtheinhalationofhighaspectrationanoparticles
AT fosterejohan invitrotestingstrategytowardsmimickingtheinhalationofhighaspectrationanoparticles
AT petrifinkalke invitrotestingstrategytowardsmimickingtheinhalationofhighaspectrationanoparticles
AT rothenrutishauserbarbara invitrotestingstrategytowardsmimickingtheinhalationofhighaspectrationanoparticles
AT wederchristoph invitrotestingstrategytowardsmimickingtheinhalationofhighaspectrationanoparticles
AT cliftmartinjd invitrotestingstrategytowardsmimickingtheinhalationofhighaspectrationanoparticles